Walking into a research clinic appointment can feel like stepping into a different language. Researchers and clinicians use precise terms that may be unfamiliar to you. Understanding these terms as they come up during your experience can help you feel more confident and ask better questions.
You do not need to memorise clinical terminology before you enrol. What you do need is a sense of how to approach terms you do not recognise—and a reference for the most common ones you will likely hear.
Eligibility criteria. These are the rules that determine whether you can participate in a trial. Age, health status, previous treatments, and lifestyle factors all figure into eligibility. You might hear “You meet our eligibility criteria” or “Your blood pressure is outside our range.” These are not judgments about you. They are checkpoints to make sure the trial is appropriate for you and you are safe.
Adverse event. This means a side effect or unexpected health problem that happens during the trial. Some adverse events are minor (headache, nausea). Some are serious. If you experience something unexpected, tell the research team immediately. They will record it as an adverse event and assess whether it is related to the treatment or something coincidental.
Placebo. A placebo is an inactive substance designed to look identical to the real treatment. In many trials, some participants receive placebo and others receive the actual drug. This helps researchers know whether improvements come from the treatment itself or from other factors like expectation or time. You will always be told if placebo is possible in your trial.
Double-blind. This means neither you nor the research team knows which participants are receiving the real drug and which are receiving placebo. This prevents bias. No one is withholding information from you—both the researchers and you are not told. Once the trial data is analysed, the information is revealed.
Randomisation. This means researchers assign participants to different groups using a method like a random number generator, not by choice. You might be randomised to the treatment group or the control group. Randomisation is fair—it prevents bias in who gets which treatment.
Protocol. This is the written plan for the trial. It describes what will happen at each visit, what tests you will have, what treatment you will receive, and what information you will be asked to provide. If someone refers to “the protocol,” they mean this study plan.
Informed consent. This is the process of understanding the trial and agreeing to participate. It includes reading information, asking questions, and signing a form confirming your understanding and agreement. Informed consent happens before you enrol, but the conversation continues throughout the trial.
Endpoint. This is the main outcome researchers are measuring. If the trial is testing a heart medication, the endpoint might be “reduction in blood pressure” or “improvement in heart function.” There are often multiple endpoints—some primary (the main thing being tested) and some secondary (additional things being monitored).
Biomarker. A biomarker is a measurable indicator of something happening in your body. Blood pressure is a biomarker. Cholesterol level is a biomarker. Enzyme levels in blood are biomarkers. Researchers measure biomarkers to understand whether a treatment is working.
Control group. In many trials, one group receives the new treatment being tested and another group receives either standard treatment or placebo. The control group is the comparison. It helps researchers know whether outcomes are due to the new treatment or would have happened anyway.
Phase. Clinical trials happen in phases. Phase 1 tests safety in small numbers of people. Phase 2 tests whether the treatment shows promise. Phase 3 tests effectiveness in larger groups and gathers more safety data. Phase 4 happens after approval and monitors long-term effects. Knowing the phase tells you what stage the research is at.
IRB (Institutional Review Board). This is an independent committee that reviews the trial before it starts and monitors it while it is happening. The IRB exists to protect participants. If something goes wrong or if new safety concerns emerge, the IRB can stop the trial.
You will likely hear other terms during your trial experience. You may encounter them in written materials, during appointments, or in study communications. When you encounter a term you do not know, ask. There is no penalty for not knowing medical or research terminology. It is not expected knowledge.
A good research team will explain terms in plain language. If an explanation is confusing, ask again. Rephrasing often helps. Asking for a written summary is reasonable. Taking notes is wise.
The purpose of clinical terminology is precision. But precision serves you—it helps the research team communicate clearly about what is happening in the trial and what is happening in your body. You are entitled to understand it.
Walking into your next appointment, you now have touchstones for the language you may hear. If new terms come up, you know they serve a purpose and you can ask for clarity. That confidence matters. **trialport** is here to support you throughout your trial journey, from understanding the basics to navigating every appointment.
